BRCA1 and BRCA2 Tumor Suppressor Function in Meiosis

被引:16
|
作者
Li, Qianyan [1 ,2 ]
Engebrecht, JoAnne [1 ,2 ]
机构
[1] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA
[2] Univ Calif Davis, Biochem Mol Cellular & Dev Biol Grad Grp, Davis, CA 95616 USA
基金
美国国家卫生研究院;
关键词
BARD1; BRCA1; BRCA2; DSBs; meiosis; MSCI; recombination; EARLY EMBRYONIC LETHALITY; STRAND BREAK FORMATION; CELL-CYCLE CHECKPOINT; DNA-DAMAGE RESPONSE; DOMAIN BARD1 GENE; CANCER SUSCEPTIBILITY; RADIATION HYPERSENSITIVITY; MEIOTIC CROSSOVERS; CROSSING-OVER; REPAIR;
D O I
10.3389/fcell.2021.668309
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Meiosis is a specialized cell cycle that results in the production of haploid gametes for sexual reproduction. During meiosis, homologous chromosomes are connected by chiasmata, the physical manifestation of crossovers. Crossovers are formed by the repair of intentionally induced double strand breaks by homologous recombination and facilitate chromosome alignment on the meiotic spindle and proper chromosome segregation. While it is well established that the tumor suppressors BRCA1 and BRCA2 function in DNA repair and homologous recombination in somatic cells, the functions of BRCA1 and BRCA2 in meiosis have received less attention. Recent studies in both mice and the nematode Caenorhabditis elegans have provided insight into the roles of these tumor suppressors in a number of meiotic processes, revealing both conserved and organism-specific functions. BRCA1 forms an E3 ubiquitin ligase as a heterodimer with BARD1 and appears to have regulatory roles in a number of key meiotic processes. BRCA2 is a very large protein that plays an intimate role in homologous recombination. As women with no indication of cancer but carrying BRCA mutations show decreased ovarian reserve and accumulated oocyte DNA damage, studies in these systems may provide insight into why BRCA mutations impact reproductive success in addition to their established roles in cancer.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] BRCA1 and BRCA2
    Bertwistle, D
    Ashworth, A
    [J]. CURRENT BIOLOGY, 2000, 10 (16) : R582 - R582
  • [2] The Brca1 and Brca2 proteins and tumor pathogenesis
    Ingvarsson, S
    [J]. ANTICANCER RESEARCH, 1999, 19 (4B) : 2853 - 2861
  • [3] In search of the tumour-suppressor functions of BRCA1 and BRCA2
    Scully, R
    Livingston, DM
    [J]. NATURE, 2000, 408 (6811) : 429 - 432
  • [4] In search of the tumour-suppressor functions of BRCA1 and BRCA2
    Ralph Scully
    David M. Livingston
    [J]. Nature, 2000, 408 : 429 - 432
  • [5] A nuclear function for the tumor suppressor BRCA1
    Monteiro, ANA
    Birge, RB
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2000, 15 (01) : 299 - 307
  • [6] Beyond BRCA1 and BRCA2
    King-Spohn, Kimberly
    Pilarski, Robert
    [J]. CURRENT PROBLEMS IN CANCER, 2014, 38 (06) : 235 - 248
  • [7] In Brief: BRCA1 and BRCA2
    Foulkes, William D.
    Shuen, Andrew Y.
    [J]. JOURNAL OF PATHOLOGY, 2013, 230 (04): : 347 - 349
  • [8] Tumor Suppressor Tolerance: Reversion Mutations in BRCA1 and BRCA2 and Resistance to PARP Inhibitors and Platinum
    Ganesan, Shridar
    [J]. JCO PRECISION ONCOLOGY, 2018, 2
  • [9] Mammary Tumor Development in Dogs Is Associated with BRCA1 and BRCA2
    Rivera, Patricio
    Melin, Malin
    Biagi, Tara
    Fall, Tove
    Haggstrom, Jens
    Lindblad-Toh, Kerstin
    von Euler, Henrik
    [J]. CANCER RESEARCH, 2009, 69 (22) : 8770 - 8774
  • [10] STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
    Clark, Serena L.
    Rodriguez, Ana M.
    Snyder, Russell R.
    Hankins, Gary D. V.
    Boehning, Darren
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2012, 1 (01):